"Over AUD $4M in costs to achieve this NASDAQ listing ... Let's...

"Over AUD $4M in costs to achieve this NASDAQ listing ... Let's hope it delivers CardieX into a Med-Tech environment that facilitates a market value reset for the company."

Hope? Many people would be aiming to recoup their losses more than making a profit. It has been a disastrous cap raise. We can add $20m dilution cost (15c s/p fall) caused by the listing delay and doubt about the listing price. So that's $24m cost to raise $12m. And the directors are rewarding themselves with bonus shares for getting the mere admin task done. Horrifying performance.